Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference

MONTREAL, May 11, 2023

Nicholas Sosiak, Chief Financial Officer of Cannara will give a presentation outlining Cannara's brief history, its current state of operations and the opportunity ahead for existing and potential new shareholders on Thursday May 18^th at 9:00 am ET.  For those interested in listening to the presentation, you may register for the event here:  https://wsw.com/webcast/canaccord88/love.v/2788332. Investors that are unable to attend the live presentation will have the opportunity to watch a recording on the investor page of the company website cannara.ca.

Nicholas Sosiak, Chief Financial Officer of Cannara commented, "We are excited to have been selected to present at one of the premier cannabis conferences in the industry.  Cannara has achieved so much in its brief existence, the management team and I are very proud of our accomplishments. I look forward to showcasing the Cannara name to all of the reputable investors taking part in this tremendous event".

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Québec and Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 120,000kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cannara-biotech-inc-to-participate-at-canaccord-genuitys-7th-annual-global-cannabis-conference-301811548.html